Elicera Therapeutics AB (publ) (ELIC.ST)

SEK 1.71

(-0.29%)

Eps Summary of Elicera Therapeutics AB (publ)

  • Elicera Therapeutics AB (publ)'s latest annual eps in 2023 was -0.83 SEK , up 16.16% from previous year.
  • Elicera Therapeutics AB (publ)'s latest quarterly eps in 2024 Q2 was -0.16 SEK , up 38.46% from previous quarter.
  • Elicera Therapeutics AB (publ) reported an annual eps of -0.99 SEK in 2022, down -20.73% from previous year.
  • Elicera Therapeutics AB (publ) reported an annual eps of -0.82 SEK in 2021, down -256.52% from previous year.
  • Elicera Therapeutics AB (publ) reported a quarterly eps of -0.16 SEK for 2024 Q2, up 38.46% from previous quarter.
  • Elicera Therapeutics AB (publ) reported a quarterly eps of -0.24 SEK for 2023 Q4, up 7.69% from previous quarter.

Annual Eps Chart of Elicera Therapeutics AB (publ) (2023 - 2014)

Historical Annual Eps of Elicera Therapeutics AB (publ) (2023 - 2014)

Year Eps Eps Growth
2023 -0.83 SEK 16.16%
2022 -0.99 SEK -20.73%
2021 -0.82 SEK -256.52%
2020 -0.23 SEK -1374.36%
2019 -0.02 SEK -5100.0%
2018 -0.00 SEK 25.0%
2017 -0.00 SEK 0.0%
2016 -0.00 SEK -101.11%
2015 0.04 SEK -5.26%
2014 0.04 SEK 0.0%

Peer Eps Comparison of Elicera Therapeutics AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK -50.909%
Ziccum AB (publ) -1.54 SEK 46.104%
Modus Therapeutics Holding AB (publ) -1.01 SEK 17.822%
BioArctic AB (publ) 2.60 SEK 131.923%
Sprint Bioscience AB (publ) -0.01 SEK -13074.603%
Mendus AB (publ) -4.40 SEK 81.136%
Genovis AB (publ.) 0.94 SEK 188.298%
Intervacc AB (publ) -1.69 SEK 50.888%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -277.273%
Active Biotech AB (publ) -0.17 SEK -388.235%
Magle Chemoswed Holding AB (publ) 1.13 SEK 173.451%
Bio-Works Technologies AB (publ) -1.57 SEK 47.134%
Aptahem AB (publ) -0.05 SEK -1618.427%
Vicore Pharma Holding AB (publ) -3.22 SEK 74.224%
Kancera AB (publ) -0.80 SEK -3.75%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 91.658%
Fluicell AB (publ) -0.24 SEK -245.833%
Saniona AB (publ) -1.29 SEK 35.659%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -336.842%
Biovica International AB (publ) -2.14 SEK 61.215%
Spago Nanomedical AB (publ) -0.43 SEK -93.023%
AcouSort AB (publ) -1.29 SEK 35.659%
Xintela AB (publ) -0.13 SEK -538.462%
Abliva AB (publ) -0.09 SEK -818.142%
Egetis Therapeutics AB (publ) -1.27 SEK 34.646%
Karolinska Development AB (publ) 0.02 SEK 4250.0%
OncoZenge AB (publ) -1.36 SEK 38.971%
Amniotics AB (publ) -0.01 SEK -7445.455%
2cureX AB (publ) -1.85 SEK 55.135%
CombiGene AB (publ) -1.80 SEK 53.889%
Asarina Pharma AB (publ) -0.57 SEK -45.614%
Calliditas Therapeutics AB (publ) -8.69 SEK 90.449%
Camurus AB (publ) 7.78 SEK 110.668%
Corline Biomedical AB -0.08 SEK -885.748%
IRLAB Therapeutics AB (publ) -3.43 SEK 75.802%
Isofol Medical AB (publ) -0.23 SEK -260.87%
I-Tech AB 1.70 SEK 148.824%
Hansa Biopharma AB (publ) -15.83 SEK 94.757%
Cyxone AB (publ) -0.22 SEK -277.273%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 58.081%
Biosergen AB -0.60 SEK -38.333%
Cantargia AB (publ) -1.65 SEK 49.697%
NextCell Pharma AB -1.03 SEK 19.417%
Xspray Pharma AB (publ) -6.76 SEK 87.722%
Nanologica AB (publ) -2.05 SEK 59.512%
SynAct Pharma AB -6.64 SEK 87.5%
Annexin Pharmaceuticals AB (publ) -0.26 SEK -219.231%
Stayble Therapeutics AB (publ) -0.92 SEK 9.783%
LIDDS AB (publ) -0.63 SEK -31.746%
Lipum AB (publ) -4.45 SEK 81.348%
BioInvent International AB (publ) -5.02 SEK 83.466%
Alzinova AB (publ) -0.41 SEK -102.439%
Oncopeptides AB (publ) -1.96 SEK 57.653%
Pila Pharma AB (publ) -0.47 SEK -76.596%
Guard Therapeutics International AB (publ) -11.26 SEK 92.629%
Scandinavian ChemoTech AB (publ) -1.13 SEK 26.549%
Simris Alg AB (publ) -0.16 SEK -418.75%
Diamyd Medical AB (publ) -1.60 SEK 48.125%
Xbrane Biopharma AB (publ) -1.27 SEK 34.646%
Ascelia Pharma AB (publ) -3.24 SEK 74.383%
Diagonal Bio AB (publ) -0.32 SEK -159.375%